US · Healthcare

Oculis Holding AG Warrants (OCSAW)

Biotechnology

Oculis Holding AG Warrants (OCSAW) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for OCSAW

P/E ratio

18.00

Oculis Holding AG Warrants (OCSAW) — FAQ

What is OCSAW's P/E ratio?

The price-to-earnings (P/E) ratio for Oculis Holding AG Warrants (OCSAW) is 18.00 (data as of 2026-03-24).

Does Oculis Holding AG Warrants pay a dividend?

Dividend yield is not available in the current snapshot for Oculis Holding AG Warrants (OCSAW). Check the MyAverix Finance app for the latest dividend data.

What sector is Oculis Holding AG Warrants in?

Oculis Holding AG Warrants (OCSAW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is OCSAW listed on?

OCSAW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)